Get your Emails warmed up and ready to send
Build sender reputation and reach more inboxes with automated email warmup.
Warm up your emails
Starting at $49/month
David Kirn
Co-founder & CEO @4D Molecular Therapeutics
Signup · Get unlimited contacts
WORK HISTORY
Co-founder & CEO @4D Molecular Therapeutics
Emeryville, CA, US
4DMT (FDMT) is a clinical-stage company that harnesses the power of directed evolution for targeted genetic medicines.
EDUCATION
University of California, Berkeley
BA, Physiology, Physical Anthropology
University of California, Berkeley, Haas School of Business
Certificate of Business Excellence
Harvard Medical School
Internal Medicine Residency, Brigham & Women's Hospital
University of California, San Francisco
Masters Program: Clinical Research & Biostatistics, Clinical Research & Biostatistics
University of California, San Francisco
Fellowship, Medical Oncology
University of California, San Francisco
Doctor of Medicine (MD), Medicine
SKILLS
ABOUT DAVID KIRN
Physician-scientist, medicines designer/developer, professor, biotech entrepreneur & CEO. Career focus on viral vector-based therapeutics including gene therapy and oncolytic virus cancer immunotherapy. Co-founder & CEO of five viral vector-based therapeutic platform companies. Led multiple programs from design concept through Phase 3 clinical trials. UC Berkeley Professor actively teaching & mentoring students in biotech entrepreneurship. Awarded J&J Entrepreneur-Innovator Award, The Medicine Maker Power List Advanced Medicine Award, and PharmaVoice100 Standout Leader Award.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.